Coronavirus (COVID-19) in South Korea - statistics & facts
Case development over time
The coronavirus outbreak in South Korea began on January 23, 2020 with a tourist from China. The number slowly increased for about a month and then began to increase exponentially from the 31st patient, who became known as a super propagator while staying anonymous. In South Korea, where the population density and social contact is high, cluster infections quickly occured and the number of new cases per day in the initial outbreak peaked on March 1, 2020 with 1,062 cases for the first wave of infections.Due to the government’s quick response, millions of COVID-19 test kits were produced and made available to the public. Once the mass infection of Shincheonji followers increased uncontrollably, the South Korean government announced that it would test over 200 thousand Shincheonji followers. The second rise in infection cases occurred in August which was related to the cluster infections from one Protestant church and one clubgoer in Seoul that triggered a massive infection afterwards. In December 2020, the government announced that it was going through a third wave of infections where the daily cases recorded a new high of 1,240 cases on Christmas Eve that year. The country experienced a prolonged fourth wave starting in the summer of 2021, which lasted until early 2022. New daily cases peaked on March 17, 2022, at over 621 thousand cases. Since then, there have been an additional wave starting in July of 2022.
Vaccination plans
South Korea started vaccinations against COVID-19 in February 2021, and has continued to administer vaccinations over the months. The vaccinations for the priority group including employees at medical facilities and first respondents were scheduled to be administered until May, with the next priority groups following as scheduled. The two domestic pharmaceutical companies SK Bioscience and GS Pharma will cooperate with global vaccine companies on the vaccine distribution in the country. SK Bioscience signed a contract with AstraZeneca to manufacture vaccines for domestic and global markets.Economic impact
The spread of COVID-19 in South Korea and across the globe in 2020 heavily impacted the domestic economy. Due to the pandemic, Korea's GDP was predicted to decrease from the previous projections. The South Korean stock market was also hit by the outbreak of the coronavirus, resulting in the KOSPI index dropping under 1,600 once for the first time in 10 years. As Korea’s economy is hugely dependent on foreign trade, Korea struggled massively during the COVID-19 crisis. Nevertheless, 2021 was off to a strong start for Korean exports. Exports from South Korea in January and February 2021 were up by more than ten percent compared to the same period last year, which was before the outbreak of COVID-19. Although the pandemic continues, economic recovery seems to be anticipated this year.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.